Petra Pharma

Small molecules for the treatment of cancer and metabolic diseases to target cellular processes such as cell division, growth, trafficking, and signaling.

placeNew York City, New York, United States calendar_todayFounded 2016 groups8 employees language petrapharmacorp.com

Registered entities

Investor mix

11 investors on record; lead investors include AbbVie, Alexandria, Arch Venture Partners, Lilly.

Investor typeCountShare
Venture capital436%
Angel & family office19%
Other / undisclosed655%
Coming soon